Effects of Epidural Local Anesthetics on Propofol Induction

NCT ID: NCT02000973

Last Updated: 2014-05-16

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Study Completion Date

2014-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators designed a prospective, randomized, placebo-controlled study to determine whether thoracic epidural anesthesia(TEA) with different local anesthetics has different influences on the propofol dose during induction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

General Anesthesia Propofol Target-controlled Infusion Thoracic Epidural Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal saline

General anesthesia combined with thoracic epidural 0.9% normal saline 8ml

Group Type PLACEBO_COMPARATOR

Normal Saline

Intervention Type DRUG

General anesthesia combined with thoracic epidural 0.9% normal saline

Lidocaine

General anesthesia combined with thoracic epidural 1% lidocaine 8ml

Group Type EXPERIMENTAL

Lidocaine

Intervention Type DRUG

General anesthesia combined with thoracic epidural 1% lidocaine

Bupivacaine

General anesthesia combined with thoracic epidural 0.25% bupivacaine 8ml

Group Type EXPERIMENTAL

Bupivacaine

Intervention Type DRUG

General anesthesia combined with thoracic epidural 0.25% bupivacaine

Ropivacaine

General anesthesia combined with thoracic epidural 0.3% ropivacaine 8ml

Group Type EXPERIMENTAL

Ropivacaine

Intervention Type DRUG

General anesthesia combined with thoracic epidural 0.3% ropivacaine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lidocaine

General anesthesia combined with thoracic epidural 1% lidocaine

Intervention Type DRUG

Bupivacaine

General anesthesia combined with thoracic epidural 0.25% bupivacaine

Intervention Type DRUG

Ropivacaine

General anesthesia combined with thoracic epidural 0.3% ropivacaine

Intervention Type DRUG

Normal Saline

General anesthesia combined with thoracic epidural 0.9% normal saline

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Surgery for thoracotomies, BMI: 18-25 Kg/m2, American Society of Anesthesiologists(ASA) classification I or II.

Exclusion Criteria

liver or kidney disease, alcohol dependence, take sedative recently, contraindications for epidural anesthesia.
Minimum Eligible Age

45 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

First Hospital of China Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jun Wang

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jun Wang

Role: STUDY_CHAIR

Dept. of Anesthesiology, First Hospital of China Medical University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20131012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.